Literature DB >> 19219045

A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.

Federica Catalanotti1, Gloria Reyes, Veronika Jesenberger, Gergana Galabova-Kovacs, Ricardo de Matos Simoes, Oliviero Carugo, Manuela Baccarini.   

Abstract

Mek1 and Mek2 (also known as Map2k1 and Map2k2, respectively) are evolutionarily conserved, dual-specificity kinases that mediate Erk1 and Erk2 activation during adhesion and growth factor signaling. Here we describe a previously uncharacterized, unexpected role of Mek1 in downregulating Mek2-dependent Erk signaling. Mek1 mediates the regulation of Mek2 in the context of a previously undiscovered Mek1-Mek2 complex. The Mek heterodimer is negatively regulated by Erk-mediated phosphorylation of Mek1 on Thr292, a residue missing in Mek2. Disabling this Erk-proximal negative-feedback step stabilizes the phosphorylation of both Mek2 and Erk in cultured cells and in vivo in Mek1 knockout embryos and mice. Thus, in disagreement with the current perception of the pathway, the role of Mek1 and Mek2 in growth factor-induced Erk phosphorylation is not interchangeable. Our data establish Mek1 as the crucial modulator of Mek and Erk signaling and have potential implications for the role of Mek1 and Mek2 in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219045     DOI: 10.1038/nsmb.1564

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  47 in total

Review 1.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors.

Authors:  Walter Kolch
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

2.  Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.

Authors:  Mathew J Garnett; Sareena Rana; Hugh Paterson; David Barford; Richard Marais
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

3.  IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.

Authors:  Monideepa Roy; Zhigang Li; David B Sacks
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

5.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.

Authors:  Silvia D M Santos; Peter J Verveer; Philippe I H Bastiaens
Journal:  Nat Cell Biol       Date:  2007-02-18       Impact factor: 28.824

6.  Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1).

Authors:  A Brunet; G Pagès; J Pouysségur
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

7.  GIT1 functions as a scaffold for MEK1-extracellular signal-regulated kinase 1 and 2 activation by angiotensin II and epidermal growth factor.

Authors:  Guoyong Yin; Judith Haendeler; Chen Yan; Bradford C Berk
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.

Authors:  Florence A Scholl; Phillip A Dumesic; Deborah I Barragan; Kazutoshi Harada; Vickram Bissonauth; Jean Charron; Paul A Khavari
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  M-Coffee: combining multiple sequence alignment methods with T-Coffee.

Authors:  Iain M Wallace; Orla O'Sullivan; Desmond G Higgins; Cedric Notredame
Journal:  Nucleic Acids Res       Date:  2006-03-23       Impact factor: 16.971

View more
  69 in total

1.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

2.  Nek10 mediates G2/M cell cycle arrest and MEK autoactivation in response to UV irradiation.

Authors:  Larissa S Moniz; Vuk Stambolic
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

Review 3.  Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice.

Authors:  Sang-Yun Lee; Jason Stadanlick; Dietmar J Kappes; David L Wiest
Journal:  Semin Immunol       Date:  2010-05-14       Impact factor: 11.130

Review 4.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

5.  Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways.

Authors:  Ruchi Rastogi; Zhongliang Jiang; Nisar Ahmad; Rita Rosati; Yusen Liu; Laurent Beuret; Robert Monks; Jean Charron; Morris J Birnbaum; Lobelia Samavati
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

6.  Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Authors:  Tara C Tassin; David R Benavides; Florian Plattner; Akinori Nishi; James A Bibb
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

7.  MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression.

Authors:  Harvinder Talwar; Mohamad Bouhamdan; Christian Bauerfeld; Jaya Talreja; Rifdat Aoidi; Nicolas Houde; Jean Charron; Lobelia Samavati
Journal:  J Immunol       Date:  2019-02-01       Impact factor: 5.422

8.  MAPK signaling to the early secretory pathway revealed by kinase/phosphatase functional screening.

Authors:  Hesso Farhan; Markus W Wendeler; Sandra Mitrovic; Eugenio Fava; Yael Silberberg; Roded Sharan; Marino Zerial; Hans-Peter Hauri
Journal:  J Cell Biol       Date:  2010-06-14       Impact factor: 10.539

Review 9.  From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

Authors:  Christophe Frémin; Sylvain Meloche
Journal:  J Hematol Oncol       Date:  2010-02-11       Impact factor: 17.388

10.  From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity.

Authors:  Théodora Niault; Izabela Sobczak; Katrin Meissl; Gregory Weitsman; Daniela Piazzolla; Gabriele Maurer; Florian Kern; Karin Ehrenreiter; Matthias Hamerl; Ismail Moarefi; Thomas Leung; Oliviero Carugo; Tony Ng; Manuela Baccarini
Journal:  J Cell Biol       Date:  2009-11-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.